<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05049421</url>
  </required_header>
  <id_info>
    <org_study_id>1-10-72-207-18-2</org_study_id>
    <nct_id>NCT05049421</nct_id>
  </id_info>
  <brief_title>The SWEDEGRAFT Right-Heart-Substudy</brief_title>
  <official_title>Right Ventricular Function After Coronary Artery Bypass Grafting The SWEDEGRAFT Right-Heart-Substudy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital Skejby</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aarhus University Hospital Skejby</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      BACKGROUND&#xD;
&#xD;
      Right ventricular dysfunction is a common echocardiographic finding after cardiac surgery.&#xD;
      Pericardial disruption has been suggested as the most probable cause as the phenomenon occurs&#xD;
      within minutes after pericardial incision.&#xD;
&#xD;
      We suspect that validated two-dimensional echocardiographic measures for right ventricular&#xD;
      function might not reflect the altered RV contraction pattern including paradoxical&#xD;
      interventricular septal motion and reduced long-axis function following open cardiac surgery.&#xD;
&#xD;
      We aim to determine the prevalence and scale of right ventricular dysfunction two years after&#xD;
      CABG by applying the latest available two- and three-dimensional echocardiographic technology&#xD;
      in right ventricular evaluation. In addition, we investigate the impact of right ventricular&#xD;
      dysfunction on functional outcome.&#xD;
&#xD;
      METHODS&#xD;
&#xD;
      The Right-Heart-Study is an observational substudy of the SWEDEGRAFT trial at Aarhus&#xD;
      University Hospital in Denmark. SWEDEGRAFT is a nordic, multicenter, prospective, randomized,&#xD;
      register-based, clinical trial (ClinicalTrials.gov Identifier: NCT03501303; Ragnarsson 2020).&#xD;
      Patients for the current Right-Heart-Substudy will be recruited amongst the 269 patients&#xD;
      included in the SWEDEGRAFT trial at Aarhus University Hospital from 10 September 2018 to 25&#xD;
      May 2020. Patients are enrolled at the time of SWEDEGRAFT follow-up with cardiac-CT&#xD;
      (approximately 30 months after CABG). After written informed consent, we perform additional&#xD;
      full 2D and 3D echocardiography with special focus on RV function, collect patient-reported&#xD;
      data on functional outcome, and measure brain natriuretic peptide and hemoglobin levels.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 10, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>3D right ventricular ejection fraction</measure>
    <time_frame>30 months postoperative</time_frame>
    <description>Right ventricular function assessed by 3D echocardiography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Right ventricular strain</measure>
    <time_frame>30 months postoperative</time_frame>
    <description>Derived from two-dimensional speckle-tracking</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease-specific health-related quality of life</measure>
    <time_frame>30 months postoperative</time_frame>
    <description>Seattle Angina Questionnaire-7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of dyspnea at exertion</measure>
    <time_frame>30 months postoperative</time_frame>
    <description>NYHA class</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived exertion during exercise</measure>
    <time_frame>30 months postoperative</time_frame>
    <description>Borg CR10® Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain natriuretic peptide</measure>
    <time_frame>30 months postoperative</time_frame>
    <description>pg/mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long-term Major Adverse Cardiac and Cerebrovascular Events</measure>
    <time_frame>5 and 10 years after CABG</time_frame>
    <description>all-cause mortality, myocardial infarction, repeat hospitalization due to cardiac cause, cerebrovascular accident, repeat revascularization</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Coronary Artery Bypass Surgery</condition>
  <condition>Right-Sided Heart Failure</condition>
  <arm_group>
    <arm_group_label>Patients following CABG</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Recruitment amongst patients enrolled in SWEDEGRAFT RCT at Aarhus University Hospital scheduled for follow-up</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Echocardiography</intervention_name>
    <description>Full 2D and 3D echocardiography with special focus on right ventricular function</description>
    <arm_group_label>Patients following CABG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        SWEDEGRAFT inclusion criteria:&#xD;
&#xD;
          -  First-time non-emergent CABG patients&#xD;
&#xD;
          -  Need for at least one vein graft&#xD;
&#xD;
          -  Able to provide informed consent and accepted for isolated primary CABG.&#xD;
&#xD;
        Additional inclusion criteria for the Right-Heart-Substudy:&#xD;
&#xD;
        • Ability to meet for follow-up visit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        SWEDEGRAFT exclusion criteria:&#xD;
&#xD;
          -  No greater saphenous vein grafts available (previous vein stripping or poor vein&#xD;
             quality)&#xD;
&#xD;
          -  Age &gt; 80 years at the time of inclusion&#xD;
&#xD;
          -  Allergy to contrast dye&#xD;
&#xD;
          -  Renal failure with eGFR &lt;15 ml/min at primary inclusion&#xD;
&#xD;
          -  Coagulation disorders&#xD;
&#xD;
          -  Excessive risk of wound infection&#xD;
&#xD;
          -  Participation in other interventional trial on grafts&#xD;
&#xD;
          -  Any condition that seriously increases the risk of non-compliance or loss of follow-up&#xD;
&#xD;
          -  Pregnant women or women of child bearing potential without negative pregnancy test&#xD;
&#xD;
        Additional inclusion criteria for the Right-Heart-Substudy:&#xD;
&#xD;
        • Inability to cooperate to transthoracic echocardiography&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ivy Modrau, MD, dr.med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital Skejby</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ivy Modrau, MD, dr.med.</last_name>
    <phone>+45 24778856</phone>
    <email>ivymod@clin.au.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jesper Khedri Jensen, MD</last_name>
    <phone>+45 60177420</phone>
    <email>jesper.k.jensen@auh.rm.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aarhus University Hospital Skejby</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivy Modrau, MD, dr.med.</last_name>
      <phone>+45 24778856</phone>
      <email>ivymod@clin.au.dk</email>
    </contact>
    <contact_backup>
      <last_name>Jesper Khedri Jensen, MD</last_name>
      <phone>+45 60177420</phone>
      <email>jesper.k.jensen@auh.rm.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Ragnarsson S, Janiec M, Modrau IS, Dreifaldt M, Ericsson A, Holmgren A, Hultkvist H, Jeppsson A, Sartipy U, Ternström L, Per Vikholm MD, de Souza D, James S, Thelin S. No-touch saphenous vein grafts in coronary artery surgery (SWEDEGRAFT): Rationale and design of a multicenter, prospective, registry-based randomized clinical trial. Am Heart J. 2020 Jun;224:17-24. doi: 10.1016/j.ahj.2020.03.009. Epub 2020 Mar 13.</citation>
    <PMID>32272256</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 10, 2021</study_first_submitted>
  <study_first_submitted_qc>September 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2021</study_first_posted>
  <last_update_submitted>September 10, 2021</last_update_submitted>
  <last_update_submitted_qc>September 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aarhus University Hospital Skejby</investigator_affiliation>
    <investigator_full_name>Ivy Modrau</investigator_full_name>
    <investigator_title>Consultant Cardiac Surgeon, Associate Professor</investigator_title>
  </responsible_party>
  <keyword>2-D Echocardiography</keyword>
  <keyword>3-D Echocardiography</keyword>
  <keyword>Coronary Artery Bypass Surgery</keyword>
  <keyword>Right-Sided Heart Failure</keyword>
  <keyword>Patient Reported Outcome Measures</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Dextrocardia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

